Smoking may change how this drug works in postmenopausal women
NCT ID NCT07534176
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether smoking changes how the body processes a single dose of GS1-144 tablets. It involves 24 healthy Chinese women aged 40-65 who are postmenopausal. Researchers will measure drug levels in the blood to see if smoking affects the drug's breakdown. The goal is to understand potential drug interactions, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)
RECRUITINGShandong, Jinan, 100021, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Blue-Green algae could ease menopause symptoms — a trial puts it to the test
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Exercise before breast cancer surgery may fight fatigue and muscle loss
- MitoQ supplement may boost brain artery health in postmenopausal women
- Talking about sex after menopause: can counseling boost satisfaction?
- Exercise plus hormone therapy may cut heart risk in menopause